Ipca Laboratories (BOM:524494) Change In Receivables : ₹0 Mil (TTM As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

What is Ipca Laboratories Change In Receivables?

Ipca Laboratories's change in receivables for the quarter that ended in Dec. 2023 was ₹0 Mil. It means Ipca Laboratories's Accounts Receivable stayed the same from Sep. 2023 to Dec. 2023 .

Ipca Laboratories's change in receivables for the fiscal year that ended in Mar. 2023 was ₹-681 Mil. It means Ipca Laboratories's Accounts Receivable increased by ₹681 Mil from Mar. 2022 to Mar. 2023 .

Ipca Laboratories's Accounts Receivable for the quarter that ended in Dec. 2023 was ₹0 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Ipca Laboratories's Days Sales Outstanding for the three months ended in Dec. 2023 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Ipca Laboratories's liquidation value for the three months ended in Dec. 2023 was ₹0 Mil.

Ipca Laboratories Change In Receivables Historical Data

The historical data trend for Ipca Laboratories's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ipca Laboratories Change In Receivables Chart

Ipca Laboratories Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Change In Receivables

Get a 7-Day Free Trial

-754.90

-1,874.10

967.50

-802.40

-681.00

Ipca Laboratories Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Ipca Laboratories Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0 Mil.

Ipca Laboratories (BOM:524494) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Ipca Laboratories's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0	/	20528.6	*	91
=	0.00

2. In Ben Graham's calculation of liquidation value, Ipca Laboratories's accounts receivable are only considered to be worth 75% of book value:

Ipca Laboratories's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0	-	0	+	0.75 * 0	+	0.5 * 0
=	0

Ipca Laboratories Change In Receivables Related Terms

Thank you for viewing the detailed overview of Ipca Laboratories's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Ipca Laboratories (BOM:524494) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ipca Laboratories Ltd (BOM:524494) » Definitions » Change In Receivables

Traded in Other Exchanges

IPCALAB:India

Address

125, Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067

Website

https://www.ipca.com

Ipca Laboratories Ltd is a specialty and generic drug manufacturing company. The company's principal activity is Development, Manufacturing and Marketing of Pharmaceuticals Products. The company operates multiple subsidiaries with revenue generation split roughly between India and the rest of the world. Ipca's products are exported to more than 100 countries across the globe. Ipca has only one reportable primary business segment, pharmaceuticals.

Ipca Laboratories (BOM:524494) Headlines

No Headlines